Our Pricing

What Is Wegovy From a Licensed UK Pharmacy?

Published on: June 03, 2026

If you're researching wegovy online uk pharmacy prescription options, you'll want to understand exactly what this treatment involves. Wegovy is a once-weekly semaglutide injection licensed by the MHRA for chronic weight management in adults with a BMI of 30 or above, or 27 with weight-related health conditions [1]. At Cured Pharmacy, we provide genuine UK-licensed Wegovy from £79.00, with transparent pricing shown before your free clinical consultation.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone called glucagon-like peptide-1. This hormone regulates appetite by signalling fullness to the brain, slowing gastric emptying, and improving insulin sensitivity [1]. Unlike appetite suppressants that work solely on the central nervous system, semaglutide addresses multiple metabolic pathways simultaneously.

In the landmark STEP 1 clinical trial, participants taking Wegovy 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Approximately 86% of participants lost at least 5% of their initial body weight, and 50% lost 15% or more — results that positioned semaglutide as one of the most effective pharmacological weight management options available in the UK.

Wegovy is administered via a pre-filled pen injector once weekly, with doses gradually increased over 16-20 weeks to minimise gastrointestinal side effects. Your UK prescriber will determine your starting dose and titration schedule based on your individual tolerance and clinical response.

Wegovy Dosing Schedule and Administration

The standard Wegovy titration begins at 0.25mg weekly for the first four weeks, then increases every four weeks: 0.5mg, 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [1]. This gradual escalation allows your body to adapt and significantly reduces the likelihood of nausea, vomiting, and diarrhoea — the most commonly reported side effects.

Each pen is designed for subcutaneous injection into the abdomen, thigh, or upper arm. The injection takes seconds and uses a fine needle similar to those used for insulin. Most patients find the process straightforward after the first attempt, and our clinical team provides full administration guidance during your consultation.

If you miss a dose and it's been fewer than five days, take it as soon as you remember. If more than five days have passed, skip that dose and resume your regular schedule. Never double up doses to compensate for missed injections.

What to Expect During Titration

The titration period exists to minimise side effects, but some gastrointestinal symptoms are common as your body adjusts. Nausea typically peaks during the first few weeks at each new dose level and subsides as you adapt. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these effects. Your prescriber may slow your titration if side effects become troublesome — there's no clinical benefit to rushing the process.

Wegovy Eligibility and Prescription Requirements in the UK

Wegovy is a prescription-only medicine in the UK, meaning it requires clinical assessment by a UK-registered prescriber before it can be dispensed. NICE guidelines recommend GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3].

During your online consultation at Cured Pharmacy, a UK prescriber will review your medical history, current medications, and weight management goals. Wegovy is not suitable for everyone — contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease [1]. Pregnant or breastfeeding women should not use Wegovy.

If Wegovy isn't appropriate for your circumstances, our clinical team may recommend alternative treatments. The consultation typically takes under three minutes and is completely free, with no obligation to proceed if you're not eligible or choose not to continue.

Who Should Not Take Wegovy

Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 due to thyroid C-cell tumour risk observed in rodent studies [1]. It's also unsuitable for those with severe renal impairment, active gallbladder disease, or a history of pancreatitis. Your prescriber will assess these factors during your consultation to ensure Wegovy is safe for you.

Wegovy Side Effects and Safety Profile

The most frequently reported side effects of Wegovy are gastrointestinal: nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), and constipation (24%) [2]. These effects are typically mild to moderate, occur most commonly during dose escalation, and diminish over time as your body adapts to the medication.

Less common but more serious adverse events include acute pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). In clinical trials, serious adverse events occurred in approximately 9.8% of Wegovy patients versus 6.4% in the placebo group [2]. Your prescriber will monitor for these risks and adjust treatment if necessary.

Some patients report injection site reactions such as redness, itching, or swelling, though these are generally transient. If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction (rash, difficulty breathing, facial swelling), seek immediate medical attention and discontinue Wegovy until you've consulted a healthcare professional.

Wegovy vs Saxenda: Comparing GLP-1 Weight Loss Injections

Both Wegovy and Saxenda are GLP-1 receptor agonists licensed in the UK for weight management, but they differ in formulation, dosing frequency, and clinical efficacy. Wegovy contains semaglutide and is administered once weekly, while Saxenda contains liraglutide and requires daily injections.

Head-to-head trial data shows semaglutide produces greater weight loss than liraglutide. In the STEP 8 trial, participants on semaglutide 2.4mg weekly lost an average of 15.8% body weight versus 6.4% with liraglutide 3mg daily over 68 weeks [4]. The once-weekly dosing of Wegovy also offers greater convenience and may improve adherence compared to daily injections.

Saxenda may be preferred for patients who want the flexibility to stop treatment quickly (due to its shorter half-life) or who have previously tolerated liraglutide well. Both medications require gradual dose titration and carry similar gastrointestinal side effect profiles. Your UK prescriber will help determine which option aligns best with your clinical needs and lifestyle preferences.

Cost Considerations Between Wegovy and Saxenda

Pricing varies depending on dose and treatment duration. At Cured Pharmacy, Wegovy starts from £79.00, with transparent pricing displayed before your consultation. While both treatments represent an investment in long-term health, the once-weekly convenience of Wegovy and its superior efficacy data make it a popular choice among UK patients seeking sustainable weight management support.

Getting Wegovy from Cured Pharmacy: What to Expect

Cured Pharmacy is a UK-registered online pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispense only genuine UK-licensed medications and operate in full compliance with MHRA and GPhC regulations.

The process is straightforward: complete a free online consultation that takes under three minutes, covering your medical history, current medications, and weight management goals. A UK-registered prescriber reviews your information, typically within hours, and issues a prescription if Wegovy is clinically appropriate for you. Your medication is then dispensed by our pharmacy team and dispatched in 100% discreet packaging with next-day delivery options available.

We guarantee the lowest prices in the UK and display all costs upfront — no hidden fees or surprise charges at checkout. If you have questions at any stage, our clinical support team is available via phone at (+44) 116 4646009. Unlike some providers, we never auto-renew subscriptions or charge without explicit consent, giving you complete control over your treatment journey.

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Rubino, D. M., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.